NCT05100563View on ClinicalTrials.gov

Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

May 24, 2021

Study Completion Date

May 24, 2021

Conditions
Autism Spectrum Disorder
Interventions
DRUG

50 mg naltrexone

Medication combined with twice a week psychotherapy

Trial Locations (1)

13210

Upstate Medical University, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT05100563 - Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone | Biotech Hunter | Biotech Hunter